WT
AKAO

Wellcome Trust’s Achaogen Inc AKAO Stock Holding History

Wellcome Trust’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,125,616
Closed -$3.11M – 31
2016
Q1 		$3.11M Hold
1,125,616
– – 0.07% 29
2015
Q4 		$6.46M Hold
1,125,616
– – 0.13% 31
2015
Q3 		$6.48M Sell
1,125,616
-224,384
-17% -$1.53M 0.14% 29
2015
Q2 		$8.14M Sell
1,350,000
-48,850
-3% -$303K 0.16% 27
2015
Q1 		$13.7M Sell
1,398,850
-128,105
-8% -$1.44M 0.29% 26
2014
Q4 		$19.9M Sell
1,526,955
-48,523
-3% -$494K 0.41% 27
2014
Q3 		$14.1M Hold
1,575,478
– – 0.29% 29
2014
Q2 		$22M Hold
1,575,478
– – 0.53% 25
2014
Q1 		$24.4M Buy
+1,575,478
New +$27.2M 0.6% 25

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellcome Trust's AKAO Position: Q2 2016 in Review

Wellcome Trust sold out of Achaogen Inc (AKAO) in Q2 2016, closing a stake of 1,125,616 shares — an estimated $3.11M sold.

Wellcome Trust first reported a position in AKAO in Q1 2014 and held it in 9 quarters. The position peaked at $24.4M in Q1 2014. 45 funds tracked by Wall St. Rank hold AKAO as of Q2 2016.

  • Wellcome Trust reported no remaining Achaogen Inc position as of Q2 2016 after selling out during the quarter.
  • Wellcome Trust sold 1,125,616 Achaogen Inc shares in Q2 2016, an estimated $3.11M.
  • Wellcome Trust first reported a position in Achaogen Inc in Q1 2014 and held it in 9 quarters.
  • Wellcome Trust's Achaogen Inc position peaked at $24.4M in Q1 2014.
  • 45 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2016.

Based on Wellcome Trust's 13F filing for Q2 2016, filed 21 Jul 2016.